摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-[PtI2(5,7-di-tert-butyl-1,2,4-triazolo[1,5-a]pyrimidine)2] | 1403824-94-1

中文名称
——
中文别名
——
英文名称
cis-[PtI2(5,7-di-tert-butyl-1,2,4-triazolo[1,5-a]pyrimidine)2]
英文别名
cis-[PtI2(dbtp)2]
cis-[PtI<sub>2</sub>(5,7-di-tert-butyl-1,2,4-triazolo[1,5-a]pyrimidine)<sub>2</sub>]化学式
CAS
1403824-94-1
化学式
C26H40I2N8Pt
mdl
——
分子量
913.546
InChiKey
XHDNGGBYNPOCSK-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    cis-[PtI2(5,7-di-tert-butyl-1,2,4-triazolo[1,5-a]pyrimidine)2]silver nitrate丙酮 为溶剂, 反应 48.0h, 以93%的产率得到cis-[Pt(NO3)2(5,7-di-tert-butyl-1,2,4-triazolo[1,5-a]pyrimidine)2]
    参考文献:
    名称:
    Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine
    摘要:
    To compare the in vitro cytotoxicity of platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine (dbtp), three complexes were prepared: cis-[PtI2(dbtp)(2)] (1). cis-[Pt(NO3)(2)(dbtP)(2)] (2) and cis-[Pt(C4H4O5)(dbtp)(2)] (3). The coordination compounds have been structurally characterized by IR; H-1, C-13, N-15, Pt-195 NMR and single-crystal X-ray diffraction (1). Spectroscopic studies reveal the monodentate coordination of the heterocycle ligand (dbtp) via N(3) to platinum(II) ions. In addition, the crystal structure of (1) shows that the platinum(II) ion is located in nearly square-planar PtI2N2 environments with two heterocycle ligands (dbtp) arranged in a head-to-head orientation. The complexes have been screened for their cytotoxicity against two human cells: non-small cell lung carcinoma (A549) and breast cancer (T47D). All of the complexes demonstrated a significant antiproliferative activity against both cell lines. On the basis of these results, it is concluded that the cytotoxicity of the studied compounds against T47D follows the order: (3) < (1) < (2). (C) 2012 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.jinorgbio.2012.05.005
  • 作为产物:
    描述:
    potassium tetraiodoplatinate 、 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine乙醇 为溶剂, 反应 48.0h, 以0.101 g的产率得到cis-[PtI2(5,7-di-tert-butyl-1,2,4-triazolo[1,5-a]pyrimidine)2]
    参考文献:
    名称:
    Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine
    摘要:
    To compare the in vitro cytotoxicity of platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine (dbtp), three complexes were prepared: cis-[PtI2(dbtp)(2)] (1). cis-[Pt(NO3)(2)(dbtP)(2)] (2) and cis-[Pt(C4H4O5)(dbtp)(2)] (3). The coordination compounds have been structurally characterized by IR; H-1, C-13, N-15, Pt-195 NMR and single-crystal X-ray diffraction (1). Spectroscopic studies reveal the monodentate coordination of the heterocycle ligand (dbtp) via N(3) to platinum(II) ions. In addition, the crystal structure of (1) shows that the platinum(II) ion is located in nearly square-planar PtI2N2 environments with two heterocycle ligands (dbtp) arranged in a head-to-head orientation. The complexes have been screened for their cytotoxicity against two human cells: non-small cell lung carcinoma (A549) and breast cancer (T47D). All of the complexes demonstrated a significant antiproliferative activity against both cell lines. On the basis of these results, it is concluded that the cytotoxicity of the studied compounds against T47D follows the order: (3) < (1) < (2). (C) 2012 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.jinorgbio.2012.05.005
点击查看最新优质反应信息

同类化合物

酪氨酸,2-甲氧基-O-甲基- 达美司特 百里酚-6-磺化三(2-羟基乙基)铵 吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 吡唑并[1,5-a][1,3,5]三嗪-2,4-二胺 吡唑并[1,5-a]-1,3,5-三嗪-4-胺,N-羟基- 吡唑并[1,5-D][1,2,4]三嗪酮 吡唑并[1,5-A]-1,3,5-三嗪-2,4(1H,3H)-二酮 N4-(1,1-二甲基乙基)-7-甲基吡唑并(1,5-a)-1,3,5-三嗪-2,4-二胺盐酸盐 N'-甲酰基-4-氨基吡唑并[5,1-c][1,2,4]三嗪-3-甲酰肼 8-苄基-2-甲基-4-(N-甲基氨基)吡唑并[1,5-a]-1,3,5-三嗪 8-碘-1H,4H-吡唑并[1,5-a][1,3,5]三嗪-4-酮 8-溴-4-氯-2-(甲基硫代)吡唑并[1,5-a][1,3,5]三嗪 8-溴-2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4-醇 8-溴-2,7-二甲基-3H-吡唑并[1,5-a][1,3,5]噻嗪-4-酮 8-溴-1H,4H-吡唑并[1,5-a][1,3,5]三嗪-4-酮 7-甲基-吡唑并[1,5-a]-1,3,5-三嗪-4(1H)-酮 7-甲基-6H-吡唑并[4,5-e][1,2,3]三嗪-4-酮 7-甲基-1,7-二氢-4H-吡唑并[3,4-d][1,2,3]三嗪-4-酮2-氧化物 7-(叔丁基)吡唑并[1,5-a][1,3,5]三嗪-4(3H)-酮 5-二乙基氨基甲基-2-苯基呋喃-3-羧酸 5,6-二氢吡唑并[1,5-d][1,2,4]三嗪-4,7-二酮 4-甲氧基吡唑并[1,5-a][1,3,5]三嗪 4-氯-2-(甲硫基)吡唑并[1,5-a][1,3,5]三嗪 4-氨基-7-甲基吡唑并[5,1-C][1,2,4]三嗪-3-甲腈 4,7-二甲基吡唑并[5,1-c][1,2,4]三嗪-3-羧酸乙酯 4,7-二甲基吡唑并[5,1-C][1,2,4]三嗪-3-羧酸 4,6-二氢-6-(碘乙酰基)-3-甲基-4-亚甲基吡唑并[5,1-c][1,2,4]三嗪 3-甲氧基-2H-吡唑并[4,3-e][1,2,4]三嗪 3-(1,1-二甲基乙基)-7-(5-甲基-3-异恶唑基)-2-[(1-甲基-1H-1,2,4-三唑-5-基)甲氧基]吡唑并[1,5-d][1,2,4]三嗪 3,4-二甲基吡唑并[5,1-c][1,2,4]三嗪 2-甲基吡唑并[1,5-d][1,2,4]三嗪-4(5H)-酮 2-甲基吡唑并[1,5-a][1,3,5]三嗪-4(1H)-酮 2-甲基-4-(N-甲基氨基)-8-[(2-噻吩基)甲基]吡唑并[1,5-a]-1,3,5-三嗪 2-氨基吡唑并[1,5-a][1,3,5]三嗪-4(1H)-酮 2-Thi氧代-2,3-二氢吡唑并[1,5-a][1,3,5]噻嗪-4(1H)-酮 2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 2,4-二氨基-吡唑并(1,5-a)-S-三嗪盐酸盐半水合物 2,4-二(甲基氨基)-7-甲基吡唑并(1,5-a)-S-三嗪 1-(4,7-二甲基吡唑并[5,1-c][1,2,4]三氮杂-3-基)-1-乙酮 4-chloro-2-methylpyrazolo[1,5-a][1,3,5]triazine 8,9-Bis-(2-furyl)furo<3,2-d>-s-triazolo<4,3-c>pyrimidin N,N-dimethyl-N'-[7-methyl-3-(5-nitro-furan-2-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-formamidine (8-chloro-7-methyl-pyrazolo[1,5-a][1,3,5]triazin-4-yl)-methyl-amine methyl-phosphonothioic acid O-isopropyl ester O'-{1-[6-oxo-4-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-1,6-dihydro-pyridazin-3-yl} ester 9-bromo-3-phenyl-pyridazino[1,6-a][1,3,5]triazine-2,4-dione prop-2-ynyl 5-(1H-benzo[d][1,2,3]triazol-5-yl)-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbimidate hydrochloride 6-Acetyl-3-methyl-4-methylen-pyrazolo<3,2-c>-as-triazin 2-Methylamino-5,7-dimethyl-s-triazolo<2,3-c>pyrimidin ethyl 7-benzamido-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carboxylate